BIO CEO’s pa­tri­ot­ic piv­ot; Step for­ward for Lil­ly’s Alzheimer’s drug; Pfiz­er’s gene ther­a­py set­back; Fore­site’s $900M fund

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.